Hospitalization rates of people living with HIV in the United States, 2009

Public Health Reports

Volumn 129, Issue 2, 2014, Pages 178-186

  Bachhuber, Marcus A ^a   Southern, William N ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ETHNIC DIFFERENCE; FEMALE; GENDER; HEALTH CARE DISPARITY; HISPANIC; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEDICAL CARE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HEALTHCARE DISPARITIES; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84894257786     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491412900212     Document Type: Article

References (54)

1. Paul S, Gilbert HM, Lande L, Vaamonde CM, Jacobs J, Malak S, et al. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses 2002;18:501-6.
2. Floris-Moore M, Lo Y, Klein RS, Budner N, Gourevitch MN, Moskaleva G, et al. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;34:331-7.
3. Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, et al. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS 2008;22:1345-54.
4. Mocroft A, Barry S, Sabin CA, Lepri AC, Kinloch S, Drinkwater A, et al. The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine. AIDS 1999;13:1255-61.
5. Tashima KT, Hogan JW, Gardner LI, Korkontzelou C, Schoenbaum EE, Schuman P, et al. A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use. Clin Infect Dis 2001;33:2055-60.
6. Mocroft A, Monforte AD, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, et al. Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study. HIV Med 2004;5:437-47.
7. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44:990-7.
8. Perkins D, Meyerson BE, Klinkenberg D, Laffoon BT. Assessing HIV care and unmet need: eight data bases and a bit of perseverance. AIDS Care 2008;20:318-26.
9. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med 2008;168:1181-7.
10. Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA; HIV Research Network. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr 2012;60:249-59.
11. Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: do patients who initiate care stay in care? AIDS Patient Care STDS 2011;25:79-88.
12. Ikard K, Janney J, Hsu LC, Isenberg DJ, Scalco MB, Schwarcz S, et al. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev 2005;17(6 Suppl B):26-38.
13. Olatosi BA, Probst JC, Stoskopf CH, Martin AB, Duffus WA. Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006. AIDS 2009;23:725-30.
14. Mugavero MJ, Lin HY, Allison JJ, Willig JH, Chang PW, Marler M, et al. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis 2007;45:127-30.
15. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials 2009;10:299-305.
16. Steiner C, Elixhauser A, Schnaier J. The Healthcare Cost and Utilization Project: an overview. Eff Clin Pract 2002;5:143-51.
17. Centers for Disease Control and Prevention (US). HIV surveillance report, 2011; vol. 23. February 2013 [cited 2013 Nov 27]. Available from: URL: http://www.cdc.gov/hiv/surveillance/resources/reports/2011report/pdf/2011_HIV_Surveillance_Report_vol_23.pdf
18. Rosenblum L, Buehler JW, Morgan MW, Costa S, Hidalgo J, Holmes R, et al. HIV infection in hospitalized patients and Medicaid enrollees: the accuracy of medical record coding. Am J Public Health 1993;83:1457-9.
19. Houchens R, Elixhauser A. Final report on calculating Nationwide Inpatient Sample (NIS) variances, 2001. HCUP Methods Series Report #2003-2. June 2005 (revised June 6, 2005). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005.
20. Healthcare Cost and Utilization Project. NIS description of data elements. September 2008 [cited 2013 Nov 27]. Available from: URL: http://www.hcup-us.ahrq.gov/db/vars/race/nisnote.jsp
21. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41(RR-17):1-19.
22. Oramasionwu CU, Hunter JM, Skinner J, Ryan L, Lawson KA, Brown CM, et al. Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis 2009;9:127.
23. Gebo KA, Fleishman JA, Moore RD. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr 2005;40:609-16.
24. Lafferty WE, Hopkins SG, Honey J, Harwell JD, Shoemaker PC, Kobayashi JM. Hospital charges for people with AIDS in Washington State: utilization of a statewide hospital discharge data base. Am J Public Health 1988;78:949-52.
25. Kozak LJ, McCarthy E, Moien M. Patterns of hospital use by patients with diagnoses related to HIV infection. Public Health Rep 1993;108:571-81.
26. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58(RR-4):1-207.
27. Meng XL. Multiple-imputation inferences with uncongenial sources of input. Stat Sci 1994;9:538-58.
28. Langkamp DL, Lehman A, Lemeshow S. Techniques for handling missing data in secondary analyses of large surveys. Acad Pediatr 2010;10:205-10.
29. Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat 2007;61:79-90.
30. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001;27:85-95.
31. Schenker N, Raghunathan TE, Chiu PL, Makuc DM, Zhang GY, Cohen AJ. Multiple imputation of missing income data in the National Health Interview Survey. J Am Stat Assoc 2006;101:924-33.
32. National Center for Health Statistics (US). Vintage 2009 bridged-race postcensal population estimates of the resident population of the United States for July 1, 2000-July 1, 2009, by year, county, age, bridged race, Hispanic origin, and sex [cited 2013 Dec 4]. Available from: URL: http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm
33. Henry J. Kaiser Family Foundation. Estimated numbers of persons living with an AIDS diagnosis, all ages, by race/ethnicity. 2009 [cited 2013 Dec 4]. Available from: URL: http://kff.org/hivaids/state-indicator/persons-with-aids-diagnosis-by-re
34. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473-89.
35. SAS Institute, Inc. SAS®: Version 9.2. Cary (NC): SAS Institute, Inc.; 2011.
36. University of Michigan. IVEWare. Ann Arbor (MI): University of Michigan, Institute for Social Research, Survey Research Center, Survey Methodology Program; 2011.
37. Crum-Cianflone NF, Grandits G, Echols S, Ganesan A, Landrum M, Weintrob A, et al. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr 2010;54:248-57.
38. Yehia BR, Fleishman JA, Hicks PL, Ridore M, Moore RD, Gebo KA, et al. Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr 2010;53:397-404.
39. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep 2002;117:233-51.
40. Cunningham WE, Markson LE, Andersen RM, Crystal SH, Fleishman JA, Golin C, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr 2000;25:115-23.
41. Hirschhorn LR, McInnes K, Landon BE, Wilson IB, Ding L, Marsden PV, et al. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues 2006;16:104-12.
42. Stein MD, Piette J, Mor V, Wachtel TJ, Fleishman J, Mayer KH, et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med 1991;6:35-40.
43. Crystal S, Sambamoorthi U, Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res 1995;30:593-614.
44. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-15.
45. Mocroft A, Gill MJ, Davidson W, Phillips AN. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr 2000;24:475-82.
46. Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005;38:96-103.
47. Fleishman JA, Yehia BR, Moore RD, Gebo KA, Agwu AL. Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care 2012;50:419-27.
48. Mugavero MJ, Lin HY, Allison JJ, Giordano TP, Willig JH, Raper JL, et al. Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr 2009;50:100-8.
49. Giordano TP, Bartsch G, Zhang Y, Tedaldi E, Absalon J, Mannheimer S, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS 2010;24:287-95.
50. McGinnis KA, Fine MJ, Sharma RK, Skanderson M, Wagner JH, Rodriguez-Barradas MC, et al. Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health 2003;93:1728-33.
51. Anastos K, Schneider MF, Gange SJ, Minkoff H, Greenblatt RM, Feldman J, et al. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr 2005;39:537-44.
52. Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, et al. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS 2006;20:1531-8.
53. Silverberg MJ, Leyden W, Quesenberry CP Jr, Horberg MA. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med 2009;24:1065-72.
54. White House (US). National HIV/AIDS Strategy for the United States. Washington: White House Office of National AIDS Policy; 2010.